EHS
EHS

Pre-transplant cardio-cerebrovascular diseases impact hematopoietic cell transplant outcomes




Hematopoietic cell transplantation (HCT) is a recognized treatment option for certain blood and bone marrow cancers as well as some autoimmune and hereditary disorders.

Source link

EHS
Back to top button